Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 897-901, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, S. M.
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. M.
Right arrow Articles by Bryan, G. T.

Comparative Carcinogenicity in the Rat of 2-Hydrazinothiazoles with Nitrofuryl, Nitrophenyl, or Aminophenyl Substituents in the 4-Position1

S. M. Cohen2, E. Ertürk, J. M. Price and George T. Bryan3

The Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706 [S. M. C., E. E., G. T. B.], and Scientific Divisions, Abbott Laboratories, North Chicago, Illinois 60064 [J. M. P.]

2-Hydrazino-4-(5-nitro-2-furyl)thiazole, 2-(2, 2-dimethylhydrazino)-4-(5-nitro-2-furyl)thiazole, 2-hydrazino-4-(4-nitrophenyl)thiazole, and 2-hydrazino-4-(4-aminophenyl)thiazole were fed to female Sprague-Dawley rats, and all were found to be potent carcinogens. Each induced chiefly carcinomas of the mammary gland (32/35, 30/31, 27/34, 34/35, respectively), as well as a lower incidence of tumors of other organs. The carcinogenic relationship of these four compounds to formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide is discussed.

1 Supported in part by Grants CA-10017 and CA-10341, and Contract PH 43-66-888 from the National Cancer Institute, and by a grant from the Wisconsin Division of the American Cancer Society.

2 Medical Scientist Trainee of National Institute of General Medical Sciences (GM-01932).

3 Career Development Awardee of the National Cancer Institute (1-K4-CA-8245-01A1).

Received 5/29/69. Accepted 8/28/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.